Providing market intelligence for more than 35 years

In The News

Roku Drops Support for ‘Classic’ Streaming Boxes

When Roku launched its first product in May 2008, it was the first device able to stream Netflix to TVs. The company has since added more than 2,000 channels available through its platform, but older models provide access to only 1,200 of those.

Roku had the No. 1 selling streaming devices last year in the U.S., with 34% share of units sold, according to Parks Associates estimates. As of Q1 2015, among American broadband households that owned a streaming device, 37% had a Roku, followed by Google Chromecast at 19%, Apple TV at 17% and Amazon Fire TV devices at 14%, per Parks’ research.

The company, in explaining why it was dropping support for its older models, said that streaming technology has evolved “and so have our Roku streaming players.”

From the article "Roku Drops Support for ‘Classic’ Streaming Boxes" by Todd Spangler.

Previously In The News

With 1 Gbps speeds, Verizon’s 5G fixed wireless service will leapfrog the competition

And speeds appear to matter. Parks Associates reported way back in 2015 that fully one quarter of Americans who switched to a new ISP "did so in order to obtain a faster service at a comparable price....

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...